Pharmaceutical Manufacturing Plan for Africa is critical for pandemic preparedness, prevention and response

Michael Mynhardt; Nicaise Ndembi

doi:10.4081/jphia.2023.2861

Editorial

Pharmaceutical Manufacturing Plan for Africa is critical for pandemic preparedness, prevention and response

Michael Mynhardt, Nicaise Ndembi

About the author(s)

Michael Mynhardt, Group Executive at Avacare Health Global, Managing Director at Barrs Pharmaceutical Industries (Pty) Ltd, South Africa
Nicaise Ndembi, Office of The Director General of The Africa Center for Disease Control and Prevention (Africa CDC), Souh Africa

Full Text:

PDF (155KB)

Abstract

No abstract available.

Keywords

No related keywords in the metadata.

Metrics

Total abstract views: 50
Total article views: 13

Crossref Citations

No related citations found.

African Online Scientific Information Systems (Pty) Ltd t/a AOSIS
Reg No: 2002/002017/07
International Tel: +27 21 975 2602
5 Hafele Street, Durbanville, Cape Town, 7550, South Africa
publishing(AT)aosis.co.za replace (AT) with @

All articles published in this journal are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license, unless otherwise stated.
Website design & content: ©2024 AOSIS (Pty) Ltd. All rights reserved. No unauthorised duplication allowed.
By continuing to use this website, you agree to our Privacy Policy, Terms of Use and Security Policy.

________

Subscribe to our newsletter

Get specific, domain-collection newsletters detailing the latest CPD courses, scholarly research and call-for-papers in your field.

Journal of Public Health in Africa | ISSN: 2038-9922 (PRINT) | ISSN: 2038-9930 (ONLINE)